Home / Oxcarbazepine / Canada
CA ATC N03AF02 · updated 2 Nov 2026
Oxcarbazepine shortage in Canada
Is there an Oxcarbazepine shortage in Canada?
Yes. As of 2 Nov 2026, 4 Oxcarbazepine products are reported short in Canada, the first since 12 Oct 2018. The company estimate for the return is 6 Nov 2026. Main reason: manufacturing problem.
Also short in Germany, Italy, Belgium. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP-OXCARBAZEPINE (100) | JAMP PHARMA CORPORATION | 12 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-OXCARBAZEPINE (100) | JAMP PHARMA CORPORATION | 12 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-OXCARBAZEPINE (100) | JAMP PHARMA CORPORATION | 12 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OXCARBAZEPINE (100 BTL) | APOTEX INC | 18 Aug 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.